flutiform 125+5 mikrogram inhalationsspray, suspension
mundipharma a/s - fluticasonpropionat, formoterolfumarat dihydrat - inhalationsspray, suspension - 125+5 mikrogram
flutiform 250+10 mikrogram inhalationsspray, suspension
mundipharma a/s - fluticasonpropionat, formoterolfumarat dihydrat - inhalationsspray, suspension - 250+10 mikrogram
flutiform k-haler 125+5 mikrogram inhalationsspray, suspension
mundipharma a/s - fluticasonpropionat, formoterolfumarat dihydrat - inhalationsspray, suspension - 125+5 mikrogram
flutiform k-haler 50+5 mikrogram inhalationsspray, suspension
mundipharma a/s - fluticasonpropionat, formoterolfumarat dihydrat - inhalationsspray, suspension - 50+5 mikrogram
affera k-haler 125+5 mikrogram inhalationsspray, suspension
orifarm a/s - fluticasonpropionat, formoterolfumarat dihydrat - inhalationsspray, suspension - 125+5 mikrogram
flutiform k-haler 125+5 mikrogram inhalationsspray, suspension
2care4 aps - fluticasonpropionat, formoterolfumarat dihydrat - inhalationsspray, suspension - 125+5 mikrogram
zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibakterielle midler til systemisk brug, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
flutiform 125+5 mikrogram inhalationsspray, suspension
2care4 aps - fluticasonpropionat, formoterolfumarat dihydrat - inhalationsspray, suspension - 125+5 mikrogram
flutiform 125+5 mikrogram inhalationsspray, suspension
orifarm a/s - fluticasonpropionat, formoterolfumarat dihydrat - inhalationsspray, suspension - 125+5 mikrogram
flutiform 125+5 mikrogram inhalationsspray, suspension
abacus medicine a/s - fluticasonpropionat, formoterolfumarat dihydrat - inhalationsspray, suspension - 125+5 mikrogram